Related references
Note: Only part of the references are listed.Persistence With Immunomodulator Monotherapy Use And Incidence of Therapeutic Ineffectiveness Among Users of Immunomodulator Monotherapy in IBD
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis
Fernando Rizzello et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
Saransh Jain et al.
INTESTINAL RESEARCH (2018)
Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis
Stefanos Bonovas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
David T. Rubin et al.
JOURNAL OF CROHNS & COLITIS (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2017)
A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease
C. P. Selinger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis
Francesco Manguso et al.
PLOS ONE (2016)
Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis
Xin Zhao et al.
PLOS ONE (2016)
Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
Gert Van Assche et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Oral budesonide for induction of remission in ulcerative colitis
Mary E. Sherlock et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
Simon P. L. Travis et al.
GUT (2014)
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Oral budesonide for induction of remission in ulcerative colitis
M. E. Sherlock et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
How Do You Avoid and Treat Steroid Side Effects?
Simon Travis
INFLAMMATORY BOWEL DISEASES (2008)
Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis
F. Manguso et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis:: A multicenter, randomized, double-blind study
L. Biancone et al.
DIGESTIVE AND LIVER DISEASE (2007)
Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis:: A randomized, double-blind trial
Fabrizio Bossa et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression
Dan Turner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort
G. -T. Ho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
GR Lichtenstein et al.
GASTROENTEROLOGY (2006)
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine - A single-blind randomized controlled trial
P Gionchetti et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study
M Campieri et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study
F Rizzello et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study
F Rizzello et al.
ADVANCES IN THERAPY (2001)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
Share Paper
